Denosumab first interchangeable biosimilars approved by the US FDA
With the recent approval of the first two interchangeable biosimilars to Amgen’s PROLIA® and XGEVA® by the US FDA in March 2024, the overall count
With the recent approval of the first two interchangeable biosimilars to Amgen’s PROLIA® and XGEVA® by the US FDA in March 2024, the overall count
Pembrolizumab, a monoclonal antibody marketed under the brand name Keytruda®, was Merck & Co’s highest-grossing product in FY 2023 with sales of about 25 billion
The Ministry of Commerce and Industry released the draft Patents (2nd Amendment) Rules, 2024 on 3rd January 2024. The draft rules focus on establishing a
Patents provide intellectual property rights protection to newly invented products, services, and processes. The patentability criteria involve: To enforce these rights, patents must be registered
A patent is a legal document that bestows the inventor with an exclusive intellectual property right to prevent others from commercially exploiting the patented invention.
Patent is a type of intellectual property right that provides protection over novel inventions and, gives the innovator an exclusive right to sell, use, create
Welcome to World School of Life Sciences IP, a pioneer in empowering minds to dominate the ever-evolving landscape of patents and pharmaceutical innovations.
Copyright 2023 All right reserved by WSLI. Designed by Webpeckers.